efficacy CRL: ONS-5010 wet-AMD BLA CRL: lacks substantial evidence
Price into the decision (T-120)
Daily close, T-120 (3/13/25) through T+5. Run-up high $2.97 on 8/25/25, low $1.14 on 4/11/25 (T-120 to T-1). FDA decision 8/28/25. Historical price action, not a forecast.
Decision facts
FDA decision date2025-08-28
Outcome✗ CRL✓ source-verified
Decision-day move-54.2%
T-120 run-up (low→high)+101.0% ($0.85→$2.97)
CRL reasonefficacy: ONS-5010 wet-AMD BLA CRL: lacks substantial evidence